References
- Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–116. doi:https://doi.org/10.1016/S2214-109X(13)70145-1.
- Bourne RRA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013;1(6):e339–e349. doi:https://doi.org/10.1016/S2214-109X(13)70113-X.
- Crabb JW. The proteomics of drusen. Cold Spring Harb Perspect Med. 2014;4(7):a017194. doi:https://doi.org/10.1101/cshperspect.a017194.
- Ferris FL 3rd, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844–851. doi:https://doi.org/10.1016/j.ophtha.2012.10.036.
- Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48:257–293.
- Holz FG, Strauss EC, Schmitz-Valckenberg S. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121(5):1079-1091.
- Lambert NG, ElShelmani H, Singh MK, et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 2016;54:64–102.
- Jonasson F, Fisher DE, Eiriksdottir G, et al. Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study. Ophthalmology. 2014;121(9):1766–1772. doi:https://doi.org/10.1016/j.ophtha.2014.03.013.
- Chakravarthy U, Bailey CC, Scanlon PH, et al. Progression from early/intermediate to advanced forms of age-related macular degeneration in a large UK Cohort: rates and risk factors. Ophthalmol Retina. 2020;4(7):662–672. doi:https://doi.org/10.1016/j.oret.2020.01.012.
- Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121(6):785–792. doi:https://doi.org/10.1001/archopht.121.6.785.
- Keenan TD, Klein B, Agrón E, Chew EY, Cukras CA, Wong WT. CHOROIDAL THICKNESS AND VASCULARITY VARY WITH DISEASE SEVERITY AND SUBRETINAL DRUSENOID DEPOSIT PRESENCE IN NONADVANCED AGE-RELATED MACULAR DEGENERATION. Retina. 2020;40(4):632–642. doi:https://doi.org/10.1097/IAE.0000000000002434.
- Chew EY. The landmark beaver dam eye study ushered in modern epidemiologic research in age-related macular degeneration. Ophthalmology. 2020;127(4):S120–S121. doi:https://doi.org/10.1016/j.ophtha.2019.12.028.
- Seddon JM, Rosner B. Validated prediction models for macular degeneration progression and predictors of visual acuity loss identify high-risk individuals. Am J Ophthalmol. 2019;198:223–261. doi:https://doi.org/10.1016/j.ajo.2018.10.022.
- Sardell RJ, Persad PJ, Pan SS, et al. progression rate from intermediate to advanced age-related macular degeneration is correlated with the number of risk alleles at the CFH locus. Invest Ophthalmol Vis Sci. 2016;57(14):6107–6115. doi:https://doi.org/10.1167/iovs.16-19519.
- Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29(2):95–112. doi:https://doi.org/10.1016/j.preteyeres.2009.11.003.
- Clark SJ, Bishop PN. The eye as a complement dysregulation hotspot. Semin Immunopathol. 2017;40(1):65–74. doi:https://doi.org/10.1007/s00281-017-0649-6.
- Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73:1765–1786.
- Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A. 2006;103(7):2328–2333. doi:https://doi.org/10.1073/pnas.0408835103.
- Parmeggiani F, Romano MR, Costagliola C, et al. Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm. 2012;2012:546786. doi:https://doi.org/10.1155/2012/546786.
- Wang L, Clark ME, Crossman DK, et al. Abundant lipid and protein components of drusen. PLoS One. 2010;5(4):e10329. doi:https://doi.org/10.1371/journal.pone.0010329.
- De Cordoba SR, Tortajada A, Harris CL, Morgan BP. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology. 2012;217(11):1034–1046. doi:https://doi.org/10.1016/j.imbio.2012.07.021.
- Fritsche LG, Igl W, Bailey JN, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134–143. doi:https://doi.org/10.1038/ng.3448.
- Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102(20):7227–7232. doi:https://doi.org/10.1073/pnas.0501536102.
- Lechner J, Chen M, Hogg RE, et al. Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: complement activation in AMD. Immun Ageing. 2016;13:4. doi:https://doi.org/10.1186/s12979-016-0060-5.
- Lores-Motta L, Paun CC, Corominas J, et al. Genome-wide association study reveals variants in CFH and CFHR4 associated with systemic complement activation: implications in age-related macular degeneration. Ophthalmology. 2018;125(7):1064–1074. doi:https://doi.org/10.1016/j.ophtha.2017.12.023.
- Machalinska A, Dziedziejko V, Mozolewska-Piotrowska K, Karczewicz D, Wiszniewska B, Machalinski B. Elevated plasma levels of C3a complement compound in the exudative form of age-related macular degeneration. Ophthalmic Res. 2009;42(1):54–59. doi:https://doi.org/10.1159/000219686.
- Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci. 2009;50(12):5818–5827. doi:https://doi.org/10.1167/iovs.09-3928.
- Ristau T, Paun C, Ersoy L, et al. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels. PLoS One. 2014;9(3):e93459. doi:https://doi.org/10.1371/journal.pone.0093459.
- Scholl HP, Charbel Issa P, Walier M, et al. Systemic complement activation in age-related macular degeneration. PLoS One. 2008;3(7):e2593. doi:https://doi.org/10.1371/journal.pone.0002593.
- Sivaprasad S, Adewoyin T, Bailey TA, et al. Estimation of systemic complement C3 activity in age-related macular degeneration. Arch Ophthalmol. 2007;125(4):515–519. doi:https://doi.org/10.1001/archopht.125.4.515.
- Smailhodzic D, Klaver CC, Klevering BJ, et al. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology. 2012;119(2):339–346. doi:https://doi.org/10.1016/j.ophtha.2011.07.056.
- Lynch AM, Mandava N, Patnaik JL, et al. Systemic activation of the complement system in patients with advanced age-related macular degeneration. Eur J Ophthalmol. 2019;30(5):1120672119857896. doi:https://doi.org/10.1177/1120672119857896.
- Lynch AM, Palestine AG, Wagner BD, et al. Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging. BMJ Open Ophthalmol. 2020;5(1):e000361. doi:https://doi.org/10.1136/bmjophth-2019-000361.
- Lynch AM, Wagner BD, Palestine AG, et al. Aptamer-based proteomics in intermediate age-related macula degeneration. TVST. 2020;9(10):12. doi:https://doi.org/10.1167/tvst.9.10.12.
- Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832. doi:https://doi.org/10.1038/s41591-019-0675-0.
- Morrisette-Thomas V, Cohen AA, Fülöp T, et al. Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev. 2014;139:49–57. doi:https://doi.org/10.1016/j.mad.2014.06.005.
- Bjornstad P, Pyle L, Cherney DZI, et al. Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study. Nephrol Dial Transplant. 2018;33(7):1189–1196. doi:https://doi.org/10.1093/ndt/gfx255.
- Bandeen-Roche K, Walston JD, Huang Y, Semba RD, Ferrucci L. Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Res. 2009;12(6):403–410. doi:https://doi.org/10.1089/rej.2009.0883.
- Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol. 2014;32(1):433–459. doi:https://doi.org/10.1146/annurev-immunol-032713-120154.
- Janeway C. Immunobiology:theimmune System in Health and Disease. 6th ed. New York: Garland Science; 2005.
- Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812. doi:https://doi.org/10.1172/JCI200318921.
- Lynch AM, Patnaik JL, Cathcart JN, et al. COLORADO AGE-RELATED MACULAR DEGENERATION REGISTRY: design and clinical risk factors of the cohort. Retina. 2019;39(4):656–663. doi:https://doi.org/10.1097/IAE.0000000000002023.
- Lynch AM, Wagner BD, Weiss SJ, et al. Proteomic profiles in advanced age-related macular degeneration using an aptamer-based proteomic technology. Transl Vis Sci Technol. 2019;8(1):14. doi:https://doi.org/10.1167/tvst.8.1.14.
- Spaide RF, Ooto S, Curcio CA. Subretinal drusenoid deposits AKA pseudodrusen. Surv Ophthalmol. 2018;63:782–815.
- Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol. 1972;34(2):187–220.
- Domalpally A, Agron E, Pak JW, et al. Prevalence, risk, and genetic association of reticular pseudodrusen in age-related macular degeneration: age-related eye disease study 2 report 21. Ophthalmology. 2019;126(12):1659–1666. doi:https://doi.org/10.1016/j.ophtha.2019.07.022.
- Fan Q, Maranville JC, Fritsche L, et al. HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization. Int J Epidemiol. 2017;46(6):1891–1902. doi:https://doi.org/10.1093/ije/dyx189.
- Schick T, Steinhauer M, Aslanidis A, et al. Local complement activation in aqueous humor in patients with age-related macular degeneration. Eye (Lond). 2017;31(5):810–813. doi:https://doi.org/10.1038/eye.2016.328.
- Mullins RF, Schoo DP, Sohn EH, et al. The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning. Am J Pathol. 2014;184(11):3142–3153. doi:https://doi.org/10.1016/j.ajpath.2014.07.017.
- Whitmore SS, Sohn EH, Chirco KR, et al. Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res. 2015;45:1-29.